Your browser doesn't support javascript.
loading
Downregulation of class II phosphoinositide 3-kinase PI3K-C2ß delays cell division and potentiates the effect of docetaxel on cancer cell growth.
Cisse, Ouma; Quraishi, Muzthahid; Gulluni, Federico; Guffanti, Federica; Mavrommati, Ioanna; Suthanthirakumaran, Methushaa; Oh, Lara C R; Schlatter, Jessica N; Sarvananthan, Ambisha; Broggini, Massimo; Hirsch, Emilio; Falasca, Marco; Maffucci, Tania.
Afiliação
  • Cisse O; Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, 4 Newark Street, London, E1 2AT, UK.
  • Quraishi M; Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, 4 Newark Street, London, E1 2AT, UK.
  • Gulluni F; Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.
  • Guffanti F; Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche "Mario Negri IRCCS", Milan, Italy.
  • Mavrommati I; Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, 4 Newark Street, London, E1 2AT, UK.
  • Suthanthirakumaran M; Present address: The Institute of Cancer Research, London, UK.
  • Oh LCR; Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, 4 Newark Street, London, E1 2AT, UK.
  • Schlatter JN; Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, 4 Newark Street, London, E1 2AT, UK.
  • Sarvananthan A; Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, 4 Newark Street, London, E1 2AT, UK.
  • Broggini M; Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, 4 Newark Street, London, E1 2AT, UK.
  • Hirsch E; Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche "Mario Negri IRCCS", Milan, Italy.
  • Falasca M; Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.
  • Maffucci T; Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, 4 Newark Street, London, E1 2AT, UK.
J Exp Clin Cancer Res ; 38(1): 472, 2019 Nov 21.
Article em En | MEDLINE | ID: mdl-31752944
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias do Colo do Útero / Classe II de Fosfatidilinositol 3-Quinases / Docetaxel Tipo de estudo: Clinical_trials Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias do Colo do Útero / Classe II de Fosfatidilinositol 3-Quinases / Docetaxel Tipo de estudo: Clinical_trials Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article